Clinical Trial Update: Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluated everolimus, temozolomide, and radiation therapy in newly diagnosed glioblastoma, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain and Central Nervous System Tumors
• Glioblastoma Multiforme

Drugs mentioned

• Everolimus (everolimus)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-01-11